Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stomach Neoplasms 34Ovarian Neoplasms 31Peritoneal Neoplasms 28Fallopian Tube Neoplasms 14Colorectal Neoplasms 14Carcinoma, Ovarian Epithelial 13Appendiceal Neoplasms 7Neoplasm Metastasis 5Pancreatic Neoplasms 4Uterine Neoplasms 3Recurrence 3Pseudomyxoma Peritonei 3Neoplasms 3Carcinoma 3Uterine Cervical Neoplasms 2Sarcoma 2Peritoneal Diseases 2Mesothelioma, Malignant 2Mesothelioma 2Hyperthermic Intraperitoneal Chemotherapy 2Gastrointestinal Neoplasms 2Gastric Adenocarcinoma 2Desmoplastic Small Round Cell Tumor 2Colonic Neoplasms 2Wilms Tumor 1Stomach Diseases 1Stage â…¢ Gastric Cancer 1Stage IV Gastric Cancer With Metastasis 1Rhabdomyosarcoma 1Rectal Neoplasms 1

Interventions

tremelimumab 1durvalumab 1Sodium Chloride 1Radiotherapy 1Lidocaine 1Hyperthermic Intraperitoneal Chemotherapy 1Cystectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Invasive Bladder Cancer × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT03514888 2023-08-28

HIPEC After Radical Cystectomy for High Risk Bladder Cancer

Weill Medical College of Cornell University

Phase NA Completed
7 enrolled
Genitourinary

Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡